中國銀河(06881.HK):2019年歸母淨利51.18億元 同比增長77.27%
格隆匯1月22日丨中國銀河(06881.HK)公告,截至2019年12月31日止年度,證券市場指數震盪上行,股基交易量回升。公司把握市場機遇,堅定推進業務轉型,優化大類資產配置,證券投資業務收入、經紀業務收入均較上年實現較大幅度增長。
2019年,公司實現營業收入人民幣168.84億元,較上年增長70.11%;實現歸屬於上市公司股東的淨利潤人民幣51.18億元,較上年增長77.27%。目前,本公司總體經營穩健,各項風險控制指標均符合《證券公司風險控制指標管理辦法》要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.